Manini et al.
filtered on Celite, evaporated to dryness, and fractionated by
preparative TLC (eluant a) to afford 2 (87 mg, 82% yield, Rf )
0.48, eluant a).
MS m/z 341 ([M + H]+), 363 ([M + Na]+), 379 ([M + K]+);
ESI(+)-HRMS for C18H2915NO5 calcd 340.2016 [M + H]+, found
340.2020.
[15N]5: 1H NMR (400 MHz, CDCl3) δ (ppm) 1.80 (2H, m, H-14),
2.70 (2H, dt, J ) 7.6, 3.6 Hz, H-8), 5.41 (1H, ddt, J ) 7.2, 6.8, 3.6
Hz, H-13), 6.17 (1H, dd, J ) 15.2, 7.2 Hz, H-12), 6.49 (1H, dd, J
) 15.2, 11.6 Hz, H-11), 7.48 (1H, dd, J ) 11.6, 3.6 Hz, H-10);
LC-MS tR ) 39 min; ESI(+)-MS m/z 325 ([M - H15NO3 + H]+),
411 ([M + Na]+), 347 ([M - H15NO3 + Na]+), 427 ([M + K]+),
363 ([M - H15NO3 + K]+); ESI(-)/MS/MS m/z 387 ([M - H]-),
63 (15[NO3]-); ESI(+)-HRMS for C18H3015N2O7 calcd 388.1994
[M + H]+, found 388.1996.
Isolation of (12Z)-9-hydroxy-10-nitro-12-ottadecenoic Acid (6)
(Mixture of Stereoisomers). The reaction for compound 2 was
carried out as described for 1. After workup, preparative TLC
afforded 6 (mixture of stereoisomers) (7 mg, 9% yield, Rf ) 0.35,
eluant a).
6: 1H NMR (400 MHz, CDCl3) δ (ppm) (the superscripts a and
b are referred to the two diastereoisomers) 1.2-1.6 (2H, m, H-8),
2.02 (2H, m, H-14), 2.51b (1H, m, H-11), 2.60a (1H, m, H-11),
2.78b (1H, m, H-11), 2.91a (1H, m, H-11),4.44-4.46a,b (1H, m,
H-10), 3.90b (1H, m, H-9), 4.06a (1H, m, H-9), 5.29 (1H, m, H-12),
5.57 (1H, m, H-13); 13C NMR (100 MHz CDCl3) δ (ppm) 25.0
(CH2), 26.4a (CH2), 28.2 (CH2), 28.8b (CH2), 71.5b (CH), 72.4a
(CH), 91.7a (CH), 92.5b (CH), 121.9 (CH), 136.0 (CH), 179.1 (C);
LC-MS tR ) 16.8 e 17.2 min; ESI(+)-MS m/z 344 ([M + H]+),
366 ([M + Na]+), 382 ([M + K]+); ESI(+)-HRMS for C18H33NO5
calcd 343.2359 [M + H]+, found 343.2355.
Computational Methods. All calculations were performed with
the Gaussian package of programs.40,41 Geometries were optimized
at the DFT level of theory using the PBE0 functional with the
6-31+G(d,p) basis set.32,33 The PBE0 (also referred to as PBE1PBE)
is a hybrid functional obtained by combining a predetermined
amount of exact exchange with the Perdew-Burke-Ernzerhof
exchange and correlation functionals.31 In control calculations, the
polarizable continuum model (PCM)36-39 was used to simulate the
aqueous environment. In view of the faster convergence, a scaled
Van der Waals cavity based on universal force field (UFF) radii42
was used, and surface elements were modeled by spherical Gaussian
1
2: H NMR (300 MHz, CDCl3) δ (ppm) 2.12 (2H, dt, J ) 7.2
Hz, H-14), 2.21 (2H, dt, J ) 7.6 Hz, H-8), 3.33 (2H, d, J ) 6.9
Hz, H-11), 5.26 (1H, m, H-12), 5.48 (1H, m, H-13), 7.08 (1H, dt,
J ) 7.6, 3.9 Hz, H-9); 13C NMR (50 MHz CDCl3) δ (ppm) 25.1
(CH2), 27.9 (CH2), 28.0 (CH2), 123.8 (CH), 132.7 (CH), 136.2 (CH),
150.8 (C) 179.3 (C); LC-MS tR ) 42 min; ESI(+) m/z 326 ([M
+ H]+), 348 ([M + Na]+), 364 ([M + K]+).
Isolation of (9E,11E)-13-Hydroxy-9-nitro-9,11-octadecadienoic
Acid (3), (9E,11E)-9-Nitro-13-oxo-9,11-octadecadienoic Acid (4),
and (9E,11E)-9-Nitro-13-nitrate-9,11-octadecadienoic Acid (5). A
solution of 1 (75 mg) in ethanol (44 mL) was added to 0.1 M
phosphate buffer, pH 7.4 (178 mL) and kept at 37 °C and under
vigorous stirring. After 2 h, the reaction mixture was acidified to
pH 3 with HCl 3 M and extracted with chloroform. After drying
over anhydrous sodium sulfate and evaporation of the solvent, the
residue was fractionated by preparative TLC (eluant a) to afford 3
(11 mg, 15% yield, Rf ) 0.20, eluant a), 4 (7 mg, 9% yield, Rf )
0.30, eluant a), and 5 (5 mg, 6% yield, Rf ) 0.36, eluant a).
3: 1H NMR (400 MHz,CDCl3) δ (ppm) 1.2-1.6 (2H, m, H-14),
2.69 (2H, t, J ) 7.6 Hz, H-8), 4.33 (1H, m, H-13), 6.32 (1H, dd,
J ) 14.8, 5.2 Hz, H-12), 6.45 (1H, dd, J ) 14.8, 11.6 Hz, H-11),
7.55 (1H, d, J ) 11.6 Hz, H-10); 13C NMR (100 MHz CDCl3) δ
(ppm) 27.2 (CH2), 37.8 (CH2), 72.7 (CH), 122.8 (CH), 133.4 (CH),
150.0 (CH), 151.6 (C), 178.6 (C); LC-MS tR ) 20 min; ESI(+)-
MS5 m/z 324 ([M - H2O + H]+), 364 ([M + Na]+), 380 ([M +
K]+); ESI(-)/MS/MS m/z 340 ([M - H]-), 322 ([(M - H2O) -
H]-), 294 ([(M - NO2) - H]-), 293 ([(M - HNO2) - H]-), 46
([NO2]-).
4: 1H NMR (400 MHz,CDCl3) δ (ppm) 2.62 (2H, t, J ) 7.6 Hz,
H-14), 2.79 (2H, t, J ) 7.6 Hz, H-8), 6.64 (1H, d, J ) 15.2 Hz,
H-12), 7.28 (1H, dd, J ) 15.2, 12.0 Hz, H-11), 7.51 (1H, d, J )
12.0 Hz, H-10); 13C NMR (125 MHz CDCl3) δ (ppm) 27.2 (CH2),
42.3 (CH2), 129.6 (CH), 137.3 (CH), 156.1 (CH), 158.2 (C), 177.9
(C), 199.2 (C); LC-MS tR ) 26 min; ESI(+)-MS m/z 340 ([M +
H]+), 362 ([M + Na]+), 378 ([M + K]+); ESI(-)/MS/MS: m/z
338 ([M - H]-), 292 ([(M - NO2) - H]-), 46 ([NO2]-); ESI(+)-
HRMS for C18H29NO5 calcd. 339.2046 [M + H]+, found 339.2049.
(40) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb,
M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.;
Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci,
B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada,
M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.;
Honda, Y. ; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian,
H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.;
Stratmann, R. E.; Yazyev, O. ; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski,
J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg,
J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.;
Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.;
Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.;
Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.;
Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill,
P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A.
Gaussian 03, ReVision C.02; Gaussian, Inc.: Wallingford, CT, 2004.
(41) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb,
M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Scalmani, G.;
Kudin, K. N.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.;
Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.;
Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai,
H.; Li, X.; Hratchian, H. P., Peralta, J. E.; Izmaylov, A. F.; Heyd, J. J.; Brothers,
E.; Staroverov, V.; Zheng, G.; Kobayashi, R.; Normand, J.; Burant, J. C.; Millam,
J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo,
J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli,
C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.;
Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.;
Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.;
Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.;
Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.;
Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.;
Chen, W.; Wong, M. W.; Pople, J. A. Gaussian DeVelopment Version, ReVision
F.01; Gaussian, Inc.: Wallingford, CT, 2006.
1
5: H NMR (400 MHz, CDCl3) δ (ppm) 1.80 (2H, m, H-14),
2.70 (2H, t, J ) 7.6 Hz, H-8), 5.41 (1H, dt, J ) 7.2, 6.8 Hz, H-13),
6.17 (1H, dd, J ) 15.2, 7.2 Hz, H-12), 6.49 (1H, dd, J ) 15.2,
11.6 Hz, H-11), 7.48 (1H, d, J ) 11.6 Hz, H-10); 13C NMR (100
MHz CDCl3) δ (ppm) 27.2 (CH2), 26.4 (CH2), 83.0 (CH), 127.6
(CH), 129.3 (CH), 132.6 (CH), 153.8 (C), 179.0 (C); LC-MS tR )
39 min; ESI(+)-MS m/z 324 ([M - HNO3 + H]+), 409 ([M +
Na]+), 346 ([M - HNO3 + Na]+), 425 ([M + K]+), 362 ([M -
HNO3 + K]+); ESI(-)/MS/MS: m/z 385 ([M - H]-), 62 ([NO3]-);
ESI(+)-HRMS for C18H30N2O7 calcd 386.2053 [M + H]+, found
386.2055.
Isolation of [15N]-(9E,11E)-13-Hydroxy-9-nitro-9,11-octadeca-
dienoic ([15N]3), [15N]-(9E,11E)-9-Nitro-13-oxo-9,11-octadecadi-
enoic ([15N]4) and [15N]-(9E,11E)-9-Nitro-13-nitrate-9,11-octadec-
adienoic Acids ([15N]5). Compounds [15N]3, [15N]4, and [15N]5 were
prepared from [15N]1 following the same procedure described above
for 1.
1
[15N]3: H NMR (400 MHz,CDCl3) δ (ppm) 1.2-1.6 (2H, m,
H-14), 2.69 (2H, dt, J ) 7.6, 3.6 Hz, H-8), 4.34 (1H, m, H-13),
6.32 (1H, dd, J ) 14.2, 5.2 Hz, H-12), 6.45 (1H, dd, J ) 14.8,
11.6 Hz, H-11), 7.55 (1H, dd, J ) 11.6, 3.6 Hz, H-10); LC-MS tR
) 20 min; ESI(+)-MS5 m/z 325 ([M - H2O + H]+), 365 ([M +
Na]+), 381 ([M + K]+).
1
[15N]4: H NMR (400 MHz,CDCl3) δ (ppm) 2.61 (2H, t, J )
7.6 Hz, H-14), 2.79 (2H, dt, J ) 7.6, 3.6 Hz, H-8), 6.64 (1H, d, J
) 15.2 Hz, H-12), 7.28 (1H, dd, J ) 15.2, 12.0 Hz, H-11), 7.51
(1H, dd, J ) 12.0, 3.6 Hz, H-10); LC-MS tR ) 26 min; ESI(+)-
(42) Rappe´, A. K.; Casewit, C. J.; Colwell, K. S.; Goddard, W. A., III.; Skiff,
W. M. J. Am. Chem. Soc. 1992, 114, 10024–10035.
7524 J. Org. Chem. Vol. 73, No. 19, 2008